Crescent doubles CLO equity bet with $232m final close
The sophomore fund more than doubles its 2018 predecessor and keeps first-loss risk in-house.
Crescent Capital has closed Crescent CLO Equity Funding II at $232m (£170.7m), more than doubling the $103m its predecessor raised in 2018, in a final close first reported by Alternative Credit Investor. The $53bn credit manager, whose CLO platform dates back to 1993, said the vehicle will buy control positions in Crescent-issued CLOs and opportunistically take debt in its own vehicles and third-party CLOs.
Nilesh Mandhare, managing director and portfolio manager for Crescent's CLO issuance strategy, called the raise evidence of 'growing conviction' from institutional investors despite a competitive fundraising environment. The conviction is easier to understand once you see where the fund sits: it buys into the first-loss slice of Crescent's CLOs, the position that absorbs losses before any rated debt gets touched, so allocators who doubled down are endorsing underwriting decisions as much as brand.
The timing adds a second layer. Direct lenders are working through a sharp drop-off in origination volumes, and as this publication has argued, the CLO reset wave has become private credit's permanent liquidity valve. Managers are resetting seasoned vehicles, printing static deals from existing portfolios, and courting retail demand for AAA CLO ETFs. A dedicated equity fund is the control layer in that machinery, keeping the riskiest and potentially most lucrative part of Crescent's own capital stack in-house.
The close is a statement about structure, not spread, and the raise looks less like a cyclical bet on CLO arbitrage than the installation of a permanent funding capability, one equity vehicle at a time. In a market where managers are selling assets and raising continuation vehicles, the ones that hold their own first-loss capital will be negotiating from the stronger seat.